@article{10618,
  keywords = {Biomarkers, Case-Control Studies, *Hodgkin Disease/diagnosis, Humans, Odds Ratio, Primary health care, United Kingdom/epidemiology, Hodgkin lymphoma, blood tests, diagnostic time window, general practice, inflammatory markers},
  author = {M. Rafiq and G. Abel and C. Renzi and G. Lyratzopoulos},
  title = {Inflammatory marker testing in primary care in the year before Hodgkin lymphoma diagnosis: a UK population-based case-control study in patients aged ≤50 years},
  year = {2022},
  journal = {Br J Gen Pract},
  volume = {72},
  edition = {2022/07/12},
  number = {721},
  pages = {e546-e555},
  isbn = {0960-1643 (Print)
0960-1643},
  doi = {10.3399/bjgp.2021.0617},
  note = {1478-5242
Rafiq, Meena
Abel, Gary
Renzi, Cristina
Lyratzopoulos, Georgios
Journal Article
Br J Gen Pract. 2022 Jul 28;72(721):e546-e555. doi: 10.3399/BJGP.2021.0617. Print 2022 Aug.},
  language = {eng},
}